MPA-USA participated in the iGEM China Community Exchange (CCiC), sharing their project on using probiotics to secrete Neoeriocitrin for colorectal cancer therapy. They discussed experimental design, data analysis, and synthetic biology applications with Chinese teams, fostering cross-cultural collaboration and providing new ideas and references.

We also held a focused exchange with RDFZ-CHINA, sharing research strategies and technical approaches on probiotic therapy for colorectal cancer, which enhanced understanding and offered valuable guidance for project optimization.

MPA-USA participated in the iGEM China Community Exchange (CCiC), presenting their project on an innovative approach using probiotics to secrete novel Neoeriocitrin for colorectal cancer therapy. During the collaboration, MPA-USA engaged in academic exchanges and project discussions with Chinese teams, sharing insights on experimental design, data analysis methods, and synthetic biology applications. Through online seminars and interactive sessions, the event fostered cross-cultural team collaboration and learning, providing the iGEM China teams with new ideas and reference cases, and promoting the integration of scientific innovation and international exchange.

We conducted a focused exchange with the RDFZ-CHINA team, engaging in in-depth discussions on colorectal cancer-related research topics. Both teams shared their research strategies, experimental designs, and data analysis approaches, exploring the application of probiotics in colorectal cancer therapy and exchanging views on experimental strategies and technical routes. This interaction not only deepened our understanding of the topic but also expanded cross-team collaboration and scientific perspectives, providing valuable references for project optimization.